Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FUQQG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,463
Award facts
- Contract value 100% obligated
- $26,462.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,462.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of RINVOQ ER 15 mg tablets in units of 30, with completion scheduled for September 24, 2025. This is a competitively awarded, non-set-aside contract with performance to be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 through December 2026, which serves as the comprehensive pharmaceutical supply vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a broad portfolio of brand-name and generic medications, vaccines, and medical devices to support federal medical procurement needs. This delivery order for RINVOQ ER, a branded pharmaceutical product, exemplifies the company's role as a critical vendor within the Defense Logistics Agency's medical supply chain, providing specialty medications and pharmaceuticals essential to military healthcare operations. The award demonstrates the contractor's capability to meet federal requirements through competitive procurement processes and its continued participation in DLA's pharmaceutical prime vendor programs.
Quick answers
Who was awarded contract SPE2DB25FUQQG?
SPE2DB25FUQQG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FUQQG worth?
The government has obligated $26,463 on SPE2DB25FUQQG.
Is contract SPE2DB25FUQQG an order under another contract?
Yes. SPE2DB25FUQQG is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQQG competed?
The extent of competition for SPE2DB25FUQQG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award